Characteristics of the blood-brain barrier in pediatric brain tumors.

Authors: Gao Q, Song D, Xu D, Chai X, Ge M

The blood-brain barrier (BBB) plays a vital role in maintaining central nervous system homeostasis but poses a major obstacle to effective drug delivery in pediatric brain tumors. BBB integrity varies significantly in pediatric brain tumors compared to adult ones, and is influenced by the tumor type, molecular subtype, and anatomical location. This review discusses the heterogeneous nature of the BBB across various pediatric brain tumors, including low-grade gliomas, diffuse midline gliomas, medulloblastomas, ependymomas and craniopharyngiomas. We review histological, molecular, and imaging evidence to highlight differences in BBB permeability and their implications for therapeutic delivery and treatment resistance. Special consideration is given to advanced drug delivery strategies, such as focused ultrasound and BBB-disrupting agents, which have been tailored to the unique barrier properties of each tumor subtype. A deeper understanding of tumor-specific BBB architecture is essential for tailoring treatment strategies and improving outcomes in pediatric brain cancer.

Introduction

Purpose Drug delivery with BBB opening

Study Objective To review and synthesize current evidence on the heterogeneous blood–brain barrier characteristics across pediatric brain tumor types and their implications for therapeutic delivery and treatment strategies.

Disease model Pediatric brain tumors (including low-grade gliomas, diffuse midline gliomas, medulloblastomas, ependymomas, craniopharyngiomas)

Outcomes and Safety

Summary of Outcomes The review finds heterogeneous BBB integrity across pediatric brain tumor subtypes that critically affects drug delivery and therapeutic resistance, and highlights emerging strategies—notably focused ultrasound (FUS) and convection-enhanced delivery (CED)—to enhance delivery tailored to subtype-specific BBB features. No specific FUS parameters were tested or reported in this review.

Safety-related matter No safety concerns or adverse effects are mentioned in the provided text; the review discusses therapies (e.g., FUS, CED) but does not report adverse events or safety data.

Brain Region

Visualization unavailable

Ultrasound Parameters

Focal Characteristics Focal depth: None, Focal length: None, Aperture size: None

We are open to feedback. If you see a mistake or have a suggestion, please contact us.